Narrative Exposure Therapy for Adults With Intellectual Disability

People with ID have a substantially higher prevalence of mental health conditions when compared to the general population and are at greater risk of exposure to adverse life events. In a survey of 177 people with mild to moderate ID, 75% had experienced at least one traumatic event. It is therefore not surprising that, when compared to the general population, people with ID are more vulnerable to the development of post-traumatic stress disorder (PTSD). Whilst the research suggests that people with ID have an increased risk of developing PTSD, there is a lack of research into trauma-focused interventions for this population. This is despite evidence that people with an ID within the mild range have been found to have the necessary skills to engage in the cognitive component of cognitive behavioural therapy (CBT) and the existence of a manual of CBT for people with mild ID and mood disorders. The National Institute for Health and Care Excellence (NICE) recommends individual trauma-focused cognitive behavioural therapy (TFCBT) as a first line treatment for PTSD in adults and specifies Narrative Exposure Therapy (NET) as an example treatment. There appears to be no evidence to date of attempts to adapt NET for adults with ID and establish whether the therapeutic benefits described in the general population, in terms of reducing symptoms of trauma, are transferable to this population. This study would therefore be a first attempt in doing so. The potential clinical benefit of the research is that a NICE recommended treatment for PTSD would be adapted for adults with mild ID and, if found to be effective, would increase the evidence base for trauma specific interventions for adults with ID. This would mean a better understanding of which therapies could help to reduce symptoms of traumatic stress in this population. At a service level, research into the effectiveness of different types of therapies guides best practice meaning resources are directed at therapies most likely to yield positive outcomes for service users. The first phase of the research requires the lead investigator (Katie Marlow) to work with a speech and language therapist (SALT) to make general adaptations to the therapy and research materials for delivery with adults with mild ID. It is expected that the investigator and SALT will meet on multiple occasions. During these meetings, it is anticipated that: * Feedback will be provided on the accessibility of the participant information sheets and consent forms for adults with mild ID. * Adaptations will be made to the psychoeducation materials used within NET. * Adaptations will be made to The Change Interview protocol. * Advice will be offered on how NET sessions should be structured and delivered for adults with mild ID. This work will be triangulated by a service user focus group (adults with ID) as patient public involvement (PPI) in the study design. Service users will be asked to provide feedback on the adaptations listed above in terms of accessibility for adults with mild ID. Changes will be made in line with this feedback and sent out again if necessary to gain further feedback. The investigators will ensure that adaptations do not lose fidelity with NET by using a fidelity framework informed by the NET manual. At this point it is likely that a substantial amendment will be submitted to the Research Ethics Committee to approve the adapted materials before use in the study. The second phase of the research consists of a Sequential Measurement Single Case Study Series to explore the effectiveness of NET in reducing symptoms of traumatic stress in adults with ID. Participants will be recruited primarily from ID services in Nottinghamshire Healthcare NHS Foundation Trust. Recruitment will be extended to Derbyshire Healthcare NHS Foundation Trust and Lincolnshire Partnership NHS Foundation Trust if necessary. The initial approach will be from the Clinical Psychologist within the person's usual care team. Clinical Psychologists will be asked to explain and distribute the information sheet to potential participants on their caseload who meet the inclusion criteria. The information sheet will inform the potential participant of all aspects pertaining to taking part in the research. If the potential participant informs their Clinical Psychologist that they are interested in taking part, or would like to hear further information, the lead investigator will then contact the participant directly. If they subsequently agree to take part, they will be invited to attend an appointment with the investigator to complete a consent form. This will be at least one week after being given the information sheet. At this appointment, potential participants will be given opportunity to ask questions and invited to sign and date a written consent form prior to taking part in the study. The investigator will ask basic questions about the information sheet to check understanding and it will be recommended that a carer be present when they sign the consent form. Participants must have capacity and capability to provide consent themselves due to the potentially distressing nature of trauma work, such as NET. Capacity to consent to the research will be assessed by the investigators following guidelines outlined in the Mental Capacity Act. Once participants have consented to the research, the SALT and lead investigator will meet again to make specific adaptations to NET for the individual participant. This will involve accessing reports within participants' files, if given permission, such as the Wechsler Adult Intelligence Scale report and previous SALT reports. Following this, the lead investigator will deliver weekly sessions of NET, which have been adapted during the first phase of the research. This will be the equivalent of 12 sessions of NET and the investigators do not foresee each session lasting longer than one hour. NET is specified in NICE guidance for the treatment of PTSD in adults and therefore the participant is not receiving anything above usual treatment. Participants will be excluded from the research if they are already engaging in trauma-focused therapy with their Clinical Psychologist and no usual care will be withheld for the purposes of this study. NET sessions will take place at clinic rooms within Nottinghamshire Healthcare NHS Foundation Trust; Horizon outpatients at Highbury Hospital and the Therapy and Treatment Centre in Mansfield (depending on the participant's preference). If participants are from within Derbyshire or Lincolnshire Trusts, more appropriate clinic space will be sought. All therapy sessions will be video recorded. This serves several purposes; to aid the investigator in the narration aspect of NET; to allow narratives of traumatic experiences to be compared before and after NET; to allow the investigators to complete observational measures of the participant; and to allow sessions to be quality assured by the Chief Investigator using a fidelity framework informed by the NET manual. Participants will be asked to complete self-report measures prior to therapy (baseline), during therapy (at the start of each appointment) and after therapy (six weeks later). During therapy sessions, participants will be asked to wear an unobtrusive device (on two fingertips) to measure electrodermal activity as an indicator of their physiological arousal. The product works in conjunction with an apple/android device with the manufacturer's app installed; this device will be University of Nottingham owned. Six weeks after completing NET, participants will be asked to take part in a change interview to gain their qualitative accounts of the therapy. The investigators will ask the Assistant Psychologist working within the ID service in Nottinghamshire Healthcare NHS Foundation Trust to conduct the interview given their experience working with adults with ID. If this is not possible, it will be conducted by an independent investigator from the Doctorate in Clinical Psychology programme; the interviewer will adhere to the same confidentiality procedures as the rest of the research team. The interview will take place at the same location where therapy was completed and will be audio recorded and subsequently transcribed by the lead investigator. If the participant brings a carer to sessions, the participant will be encouraged to invite them into the initial psychoeducation session of NET to allow the carer to gain a greater understanding of the participant's trauma reactions and the potential utility of NET. The investigators will also encourage participants to invite their carer into the final part of therapy sessions for a debrief so that they are aware of the content covered and support which may be required following sessions. Carers will also be asked for their participation in the research. If consenting, they will be asked to complete measures prior to therapy (baseline), at the end of therapy (final NET session) and at the change interview six weeks later. Within the participant consent form, participants are asked for their agreement for carers to complete questionnaires regarding their presentation. Carer participants will also have access to the information sheet for participants with ID so they are informed of all aspects of the research.